Re: J. Alfred Witjes, Thierry Lebret, Eva M. Comperat, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017; 71: 462-75

被引：2

作者：

Bokarica, Pero ^{[1
]}

Hrkac, Adelina ^{[1
]}

Gilja, Ivan ^{[1
]}

机构：

[1] Clin Hosp Sveti Duh, Dept Urol, Sveti Duh 64, Zagreb 10000, Croatia

来源：

EUROPEAN UROLOGY | 2017年 / 72卷 / 02期

关键词：

D O I：

10.1016/j.eururo.2017.02.031

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E45 / E45

页数：1

共 44 条

[41] Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36
Vila-Reyes, Helena
DeCastro, G. Joel
McKiernan, James M.
EUROPEAN UROLOGY, 2021, 79 (02) : E54 - E55
[42] Reply to Slawomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohy-perthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Arends, Tom J. H.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2017, 71 (01) : E31 - E32
[43] Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Arends, Tom J. H.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2019, 75 (02) : E26 - E26
[44] Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016; 70: 1052-68 The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma
Seisen, Thomas
Babjuk, Marko
Roupret, Morgan
EUROPEAN UROLOGY, 2017, 71 (04) : E111 - E112

← 1 2 3 4 5 →